关注
Vladimir Razinkov
Vladimir Razinkov
在 amgen.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
High throughput thermostability screening of monoclonal antibody formulations
F He, S Hogan, RF Latypov, LO Narhi, VI Razinkov
Journal of pharmaceutical sciences 99 (4), 1707-1720, 2010
2132010
Effective charge measurements reveal selective and preferential accumulation of anions, but not cations, at the protein surface in dilute salt solutions
YR Gokarn, RM Fesinmeyer, A Saluja, V Razinkov, SF Chase, TM Laue, ...
Protein Science 20 (3), 580-587, 2011
1542011
Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition
SB Hari, H Lau, VI Razinkov, S Chen, RF Latypov
Biochemistry 49 (43), 9328-9338, 2010
1482010
High-throughput dynamic light scattering method for measuring viscosity of concentrated protein solutions
F He, GW Becker, JR Litowski, LO Narhi, DN Brems, VI Razinkov
Analytical biochemistry 399 (1), 141-143, 2010
1442010
Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution …
Z Wei, M Mcevoy, V Razinkov, A Polozova, E Li, J Casas-Finet, GI Tous, ...
Journal of virological methods 144 (1-2), 122-132, 2007
1162007
High‐throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations
F He, CE Woods, GW Becker, LO Narhi, VI Razinkov
Journal of pharmaceutical sciences 100 (12), 5126-5141, 2011
1112011
Effect of sugar molecules on the viscosity of high concentration monoclonal antibody solutions
F He, CE Woods, JR Litowski, LA Roschen, HS Gadgil, VI Razinkov, ...
Pharmaceutical research 28, 1552-1560, 2011
1082011
Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies
DD Banks, RF Latypov, RR Ketchem, J Woodard, JL Scavezze, CC Siska, ...
Journal of pharmaceutical sciences 101 (8), 2720-2732, 2012
1072012
RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein
V Razinkov, A Gazumyan, A Nikitenko, G Ellestad, G Krishnamurthy
Chemistry & biology 8 (7), 645-659, 2001
1002001
A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism
Z Liu, EC Leng, K Gunasekaran, M Pentony, M Shen, M Howard, J Stoops, ...
Journal of Biological Chemistry 290 (12), 7535-7562, 2015
962015
Aggregation of anti-streptavidin immunoglobulin gamma‐1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration
N Kim, RL Remmele Jr, D Liu, VI Razinkov, EJ Fernandez, CJ Roberts
Biophysical chemistry 172, 26-36, 2013
932013
Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis
F He, CE Woods, E Trilisky, KM Bower, JR Litowski, BA Kerwin, ...
Journal of pharmaceutical sciences 100 (4), 1330-1340, 2011
902011
Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools
VI Razinkov, MJ Treuheit, GW Becker
Journal of biomolecular screening 20 (4), 468-483, 2015
812015
Specific-ion effects on the aggregation mechanisms and protein–protein interactions for anti-streptavidin immunoglobulin gamma-1
GV Barnett, VI Razinkov, BA Kerwin, TM Laue, AH Woodka, PD Butler, ...
The Journal of Physical Chemistry B 119 (18), 5793-5804, 2015
792015
Effects of Spontaneous Bilayer Curvature on Influenza Virus–mediated Fusion Pores
VI Razinkov, GB Melikyan, RM Epand, RF Epand, FS Cohen
The Journal of general physiology 112 (4), 409, 1998
751998
How Well Do Low-and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?
MA Woldeyes, W Qi, VI Razinkov, EM Furst, CJ Roberts
Journal of pharmaceutical sciences, 2018
722018
Detection of IgG aggregation by a high throughput method based on extrinsic fluorescence
F He, DH Phan, S Hogan, R Bailey, GW Becker, LO Narhi, VI Razinkov
Journal of pharmaceutical sciences 99 (6), 2598-2608, 2010
702010
Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies
Z Liu, K Gunasekaran, W Wang, V Razinkov, L Sekirov, E Leng, H Sweet, ...
Journal of Biological Chemistry 289 (6), 3571-3590, 2014
662014
Sterols and sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus
VI Razinkov, FS Cohen
Biochemistry 39 (44), 13462-13468, 2000
532000
Precision of protein aggregation measurements by sedimentation velocity analytical ultracentrifugation in biopharmaceutical applications
JP Gabrielson, KK Arthur, MR Stoner, BC Winn, BS Kendrick, V Razinkov, ...
Analytical biochemistry 396 (2), 231-241, 2010
522010
系统目前无法执行此操作,请稍后再试。
文章 1–20